Xylem Research Development vs Gross Profit Analysis

XYL Stock

USD 144.25 0.53 0.37%

Xylem financial indicator trend analysis is more than just analyzing Xylem Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xylem Inc is a good investment. Please check the relationship between Xylem Research Development and its Gross Profit accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

Research Development vs Gross Profit

Research Development vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xylem Inc Research Development account and Gross Profit. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Xylem's Research Development and Gross Profit is 0.94. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Xylem Inc, assuming nothing else is changed. The correlation between historical values of Xylem's Research Development and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Xylem Inc are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Research Development i.e., Xylem's Research Development and Gross Profit go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Xylem Inc minus its cost of goods sold. It is profit before Xylem operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Xylem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xylem Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

The value of Selling General Administrative is expected to slide to about 1.2 B. The value of Tax Provision is estimated to slide to about 79.7 M

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	2.1B	2.7B	1.9B
Total Revenue	5.2B	5.5B	7.4B	4.9B

Gross Profit Total Revenue

Xylem fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Common Stock Shares Outstanding		0.78	0.47	0.41	0.9	-0.09	0.86	0.07	0.5	0.11	0.81	0.05	0.54	0.11	0.68	0.84	-0.04	0.16	0.59	0.41	0.24	0.71	0.44	0.73	-0.04	0.25
Total Assets	0.78		0.82	0.73	0.96	0.46	0.98	0.44	0.76	0.43	0.99	0.47	0.86	0.43	0.79	0.99	-0.34	0.62	0.75	0.68	0.67	0.9	0.71	0.97	-0.34	0.68
Other Current Liab	0.47	0.82		0.77	0.72	0.62	0.74	0.35	0.82	0.57	0.79	0.66	0.88	0.57	0.72	0.75	-0.09	0.66	0.71	0.52	0.72	0.8	0.76	0.77	-0.09	0.71
Total Current Liabilities	0.41	0.73	0.77		0.56	0.75	0.62	0.63	0.91	0.68	0.69	0.73	0.79	0.68	0.85	0.65	-0.4	0.87	0.84	0.8	0.94	0.61	0.9	0.72	-0.4	0.89
Total Stockholder Equity	0.9	0.96	0.72	0.56		0.2	0.99	0.25	0.63	0.27	0.97	0.27	0.77	0.27	0.72	0.98	-0.18	0.39	0.67	0.53	0.45	0.89	0.57	0.92	-0.18	0.47
Other Liab	-0.09	0.46	0.62	0.75	0.2		0.31	0.72	0.64	0.64	0.41	0.79	0.56	0.64	0.47	0.35	-0.45	0.92	0.48	0.62	0.89	0.32	0.66	0.5	-0.45	0.86
Property Plant And Equipment Net	0.86	0.98	0.74	0.62	0.99	0.31		0.39	0.67	0.27	0.99	0.31	0.77	0.27	0.76	1.0	-0.26	0.49	0.69	0.61	0.55	0.87	0.59	0.97	-0.26	0.58
Net Debt	0.07	0.44	0.35	0.63	0.25	0.72	0.39		0.61	0.09	0.46	0.33	0.27	0.09	0.58	0.42	-0.56	0.79	0.48	0.75	0.76	0.23	0.36	0.6	-0.56	0.85
Accounts Payable	0.5	0.76	0.82	0.91	0.63	0.64	0.67	0.61		0.51	0.73	0.63	0.79	0.51	0.95	0.7	-0.36	0.82	0.95	0.82	0.87	0.75	0.86	0.75	-0.36	0.88
Cash	0.11	0.43	0.57	0.68	0.27	0.64	0.27	0.09	0.51		0.33	0.85	0.73	1.0	0.39	0.28	-0.37	0.65	0.5	0.44	0.68	0.41	0.86	0.3	-0.37	0.51
Non Current Assets Total	0.81	0.99	0.79	0.69	0.97	0.41	0.99	0.46	0.73	0.33		0.39	0.81	0.33	0.79	1.0	-0.3	0.57	0.72	0.66	0.63	0.88	0.64	0.99	-0.3	0.66
Non Currrent Assets Other	0.05	0.47	0.66	0.73	0.27	0.79	0.31	0.33	0.63	0.85	0.39		0.71	0.85	0.49	0.33	-0.39	0.78	0.54	0.47	0.79	0.44	0.81	0.4	-0.39	0.69
Other Assets	0.54	0.86	0.88	0.79	0.77	0.56	0.77	0.27	0.79	0.73	0.81	0.71		0.73	0.71	0.78	-0.34	0.68	0.8	0.61	0.73	0.9	0.88	0.77	-0.34	0.68
Cash And Short Term Investments	0.11	0.43	0.57	0.68	0.27	0.64	0.27	0.09	0.51	1.0	0.33	0.85	0.73		0.39	0.28	-0.37	0.65	0.5	0.44	0.68	0.41	0.86	0.3	-0.37	0.51
Net Receivables	0.68	0.79	0.72	0.85	0.72	0.47	0.76	0.58	0.95	0.39	0.79	0.49	0.71	0.39		0.77	-0.39	0.72	0.94	0.84	0.78	0.73	0.8	0.79	-0.39	0.81
Good Will	0.84	0.99	0.75	0.65	0.98	0.35	1.0	0.42	0.7	0.28	1.0	0.33	0.78	0.28	0.77		-0.27	0.52	0.7	0.63	0.57	0.87	0.6	0.98	-0.27	0.6
Common Stock Total Equity	-0.04	-0.34	-0.09	-0.4	-0.18	-0.45	-0.26	-0.56	-0.36	-0.37	-0.3	-0.39	-0.34	-0.37	-0.39	-0.27		-0.64	-0.42	-0.73	-0.58	-0.23	-0.47	-0.36	1.0	-0.58
Non Current Liabilities Total	0.16	0.62	0.66	0.87	0.39	0.92	0.49	0.79	0.82	0.65	0.57	0.78	0.68	0.65	0.72	0.52	-0.64		0.72	0.84	0.99	0.5	0.81	0.65	-0.64	0.97
Inventory	0.59	0.75	0.71	0.84	0.67	0.48	0.69	0.48	0.95	0.5	0.72	0.54	0.8	0.5	0.94	0.7	-0.42	0.72		0.83	0.78	0.81	0.86	0.71	-0.42	0.78
Other Current Assets	0.41	0.68	0.52	0.8	0.53	0.62	0.61	0.75	0.82	0.44	0.66	0.47	0.61	0.44	0.84	0.63	-0.73	0.84	0.83		0.85	0.56	0.75	0.71	-0.73	0.85
Total Liab	0.24	0.67	0.72	0.94	0.45	0.89	0.55	0.76	0.87	0.68	0.63	0.79	0.73	0.68	0.78	0.57	-0.58	0.99	0.78	0.85		0.55	0.87	0.69	-0.58	0.97
Property Plant And Equipment Gross	0.71	0.9	0.8	0.61	0.89	0.32	0.87	0.23	0.75	0.41	0.88	0.44	0.9	0.41	0.73	0.87	-0.23	0.5	0.81	0.56	0.55		0.69	0.83	-0.23	0.56
Total Current Assets	0.44	0.71	0.76	0.9	0.57	0.66	0.59	0.36	0.86	0.86	0.64	0.81	0.88	0.86	0.8	0.6	-0.47	0.81	0.86	0.75	0.87	0.69		0.62	-0.47	0.77
Intangible Assets	0.73	0.97	0.77	0.72	0.92	0.5	0.97	0.6	0.75	0.3	0.99	0.4	0.77	0.3	0.79	0.98	-0.36	0.65	0.71	0.71	0.69	0.83	0.62		-0.35	0.73
Common Stock	-0.04	-0.34	-0.09	-0.4	-0.18	-0.45	-0.26	-0.56	-0.36	-0.37	-0.3	-0.39	-0.34	-0.37	-0.39	-0.27	1.0	-0.64	-0.42	-0.73	-0.58	-0.23	-0.47	-0.35		-0.58
Property Plant Equipment	0.25	0.68	0.71	0.89	0.47	0.86	0.58	0.85	0.88	0.51	0.66	0.69	0.68	0.51	0.81	0.6	-0.58	0.97	0.78	0.85	0.97	0.56	0.77	0.73	-0.58

Click cells to compare fundamentals

Xylem Account Relationship Matchups

Xylem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	181.2M	181.1M	181.5M	181.0M	218.2M	203.7M
Total Assets	7.7B	8.8B	8.3B	8.0B	16.1B	16.9B
Other Current Liab	628M	787M	683M	798M	945M	992.3M
Total Current Liabilities	1.5B	2.0B	1.4B	1.6B	2.2B	1.3B
Total Stockholder Equity	3.0B	3.0B	3.2B	3.5B	10.2B	10.7B
Other Liab	1.0B	1.3B	1.2B	730M	839.5M	787.3M
Property Plant And Equipment Net	658M	657M	644M	630M	1.5B	1.6B
Net Debt	1.6B	1.2B	1.1B	1.0B	1.6B	1.2B
Accounts Payable	597M	569M	639M	723M	968M	536.4M
Cash	724M	1.9B	1.3B	944M	1.0B	721.5M
Non Current Assets Total	5.3B	5.2B	5.1B	4.9B	12.2B	12.8B
Non Currrent Assets Other	589M	623M	664M	360M	415M	325.2M
Other Assets	348M	623M	664M	661M	760.2M	798.2M
Cash And Short Term Investments	724M	1.9B	1.3B	944M	1.0B	721.5M
Net Receivables	1.0B	923M	953M	1.1B	1.6B	998.3M
Good Will	2.8B	2.9B	2.8B	2.7B	7.6B	8.0B
Liabilities And Stockholders Equity	7.7B	8.8B	8.3B	8.0B	16.1B	16.9B
Non Current Liabilities Total	3.2B	3.8B	3.7B	2.9B	3.7B	2.7B
Inventory	539M	558M	700M	799M	1.0B	601.9M
Other Current Assets	151M	167M	158M	173M	230M	159.6M
Total Liab	4.7B	5.8B	5.1B	4.4B	5.9B	4.0B
Property Plant And Equipment Gross	658M	657M	1.8B	1.8B	2.5B	2.6B
Total Current Assets	2.5B	3.5B	3.2B	3.0B	3.9B	2.5B
Accumulated Other Comprehensive Income	(375M)	(413M)	(371M)	(226M)	(269M)	(255.6M)
Intangible Assets	1.2B	1.1B	1.0B	930M	2.5B	2.7B
Property Plant Equipment	658M	657M	644M	630M	724.5M	599.5M
Short Long Term Debt Total	2.3B	3.1B	2.4B	1.9B	2.7B	2.2B
Net Tangible Assets	(1.1B)	(979M)	(590M)	(155M)	(139.5M)	(146.5M)
Noncontrolling Interest In Consolidated Entity	14M	10M	8M	9M	10.4M	7.5M
Retained Earnings	1.9B	1.9B	2.2B	2.3B	2.6B	1.4B
Long Term Debt	2.0B	2.5B	2.4B	1.9B	2.3B	2.0B
Retained Earnings Total Equity	1.9B	1.9B	2.2B	2.3B	2.6B	1.3B
Long Term Debt Total	2.0B	2.5B	2.4B	1.9B	2.2B	1.9B
Capital Surpluse	2.0B	2.0B	2.1B	2.1B	2.5B	2.1B
Other Stockholder Equity	1.5B	1.4B	1.4B	1.4B	7.8B	8.2B
Deferred Long Term Liab	310M	242M	287M	222M	255.3M	254.2M
Treasury Stock	(527M)	(588M)	(656M)	(708M)	(637.2M)	(605.3M)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Xylem Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Xylem Inc is a strong investment it is important to analyze Xylem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xylem's future performance. For an informed investment choice regarding Xylem Stock, refer to the following important reports:

How To Invest In Xylem

Details

Is Xylem Stock a good investment?

Details

What is Xylem's Net Worth?

Details

Largest Industrial Machinery & Supplies & Components Companies

View

Largest Specialty Industrial Machinery Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Xylem Stock analysis

When running Xylem's price analysis, check to measure Xylem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xylem is operating at the current time. Most of Xylem's value examination focuses on studying past and present price action to predict the probability of Xylem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xylem's price. Additionally, you may evaluate how the addition of Xylem to your portfolios can decrease your overall portfolio volatility.

	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Is Xylem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.167

Dividend Share

1.35

Earnings Share

2.89

Revenue Per Share

34.207

Quarterly Revenue Growth

0.404

The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xylem Research Development vs Gross Profit Analysis

Research Development vs Gross Profit

Research Development vs Gross Profit Correlation Analysis

Correlation Coefficient

Research Development

Gross Profit

Xylem fundamental ratios Correlations

Xylem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Xylem fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Xylem Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Good Will	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 1.0	Non Current Assets Total
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Assets Total	+ 0.99	Total Assets
Good Will	+ 0.99	Total Assets

Common Stock	- 0.73	Other Current Assets
Other Current Assets	- 0.73	Common Stock Total Equity
Common Stock	- 0.64	Non Current Liabilities Total
Non Current Liabilities Total	- 0.64	Common Stock Total Equity
Property Plant Equipment	- 0.58	Common Stock
Common Stock	- 0.58	Total Liab